Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,322 | -10,270 | -10,000 | -8,870 | -11,760 |
| Depreciation Amortization | 681 | 680 | 760 | 2,520 | 4,920 |
| Accounts payable and accrued liabilities | -47 | -188 | N/A | N/A | N/A |
| Other Working Capital | 416 | -385 | 430 | 40 | 80 |
| Other Operating Activity | 2,677 | 3,042 | 2,970 | 2,040 | 2,980 |
| Operating Cash Flow | $-8,596 | $-7,120 | $-5,840 | $-4,270 | $-3,780 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | N/A | -20 | -20 | -10 |
| Purchase Of Investment | N/A | -3,986 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 8,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -230 | -6,310 | 0 |
| Investing Cash Flow | $-6 | $4,014 | $-250 | $-6,330 | $-10 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,519 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 2,524 | 2,640 | 5,810 | 4,370 | 10,660 |
| Financing Cash Flow | $9,043 | $2,640 | $5,810 | $4,370 | $10,660 |
| Beginning Cash Position | 2,796 | 3,263 | 630 | 6,870 | 10 |
| End Cash Position | 3,237 | 2,796 | 350 | 630 | 6,870 |
| Net Cash Flow | $441 | $-467 | $-280 | $-6,240 | $6,860 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,596 | -7,120 | -5,840 | -4,270 | -3,780 |
| Capital Expenditure | -6 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -8,602 | -7,120 | -5,840 | -4,270 | -3,780 |